Vanguard World Fund has announced its latest financial results in a recent filing, indicating a robust performance with substantial assets under management. This filing is significant as it reflects the fund's ability to attract and retain investors in a competitive investment landscape.
The Vanguard World Fund, classified as an investment entity, operates under the Central Index Key (CIK) number 0000052848. The fund is registered in Delaware and primarily focuses on managing investment portfolios. Vanguard has a long-standing reputation for its low-cost investment options and has consistently been a leader in the investment management industry.
According to the filing dated October 29, 2026, Vanguard World Fund reported total assets of approximately $13.52 billion, with net assets amounting to about $13.52 billion as well. The filing also detailed that the fund had total liabilities of around $533,371.54. This data underscores the fund's strong financial position and its capability to manage significant assets effectively.
The filing also disclosed the fund's monthly returns, indicating a mix of performance results. For instance, the fund experienced a return of -1.02% in the first month, followed by -0.41% and a positive return of 3.18% in the subsequent months. Such fluctuations may impact investor sentiment and influence decisions in the investment management sector.
Vanguard World Fund's latest filing may affect various stakeholders, including investors, financial advisors, and competitors in the investment management industry. Investors may look closely at these results to assess the fund's performance and make informed investment decisions. Financial advisors will likely consider this information when recommending investment strategies to their clients.
As for what’s next, the filing does not specify any immediate actions or upcoming events related to the fund. Investors and analysts will be keen to see how Vanguard continues to navigate the competitive landscape of investment management in the coming months.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






